Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice

Go back to Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Delayed: 1.03 --0 (-0%)
Previous Close $1.03    52 Week High $3.50 
Open $1.02    52 Week Low $0.86 
Day High $1.05    P/E N/A 
Day Low $1.02    EPS $-7.61 
Volume 71,860